Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population

Lupus

Volumn 16, Issue 11, 2007, Pages 867-874

  Vazgiourakis, V ^a   Sidiropoulos, P ^b   Bertsias, G ^b   Koutsounaki, E ^a   Fragouli, E ^a   Raptopoulou, A ^b   Kritikos, H ^b   Boumpas, D T ^a,b   Goulielmos, G N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Endothelial nitric oxide synthase gene; eNOS polymorphism; Nitric oxide (NO); Rheumatoid arthritis (RA); Systematic lupus erythematosus (SLE)

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GREECE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36349009241     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307083179     Document Type: Article

References (36)

1. Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metabol 2000; 70: 241-251.
2. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: The good, the bad and the ugly. Am J Physiol 1996; 271: C1424-C1437.
3. Marletta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994; 78: 927-930.
4. Marsden PA, Heng HH, Scherer SW et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488.
5. Sase K, Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci 1995; 57: 2049-2055.
6. Hunley TE, Iwasaki S, Homma T, Kon V. Nitric oxide and endothelin in pathophysiological settings. Pediatr Nephrol 1995; 9: 235-244.
7. Heeringa P, van Goor H, Moshage HP et al. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. Kidney Int 1998; 53: 382-393.
8. Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999; 26: 318-324.
9. Wanchu A, Khullar M, Deodhar SD, Bambery P, Sud A. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 1998; 8: 41-43.
10. Gonzalez-Crespo MR, Navarro JA, Arenas, Martin-Mola E, De La Cruz J, Gomez-Reino JJ. Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus. Br J Rheumatol 1998; 37: 972-977.
11. Furusu A, Miyazaki M, Abe K et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53: 382-393.
12. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998; 41: 1141-1151.
13. St Clair EW, Wilkinson WE, Lang T et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 1996; 184: 1173-1178.
14. Van't Hof RJ, Hocking L, Wright PK, Ralston SH. Nitric oxide is a mediator of apoptosis in rheumatoid joints. Rheumatology 2000; 39: 1004-1008.
15. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 1998; 19: 556-561.
16. Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 1992; 13: 157-160.
17. Yki-Jarvinen H, Bergholm R, Leirisalo-Repo M. Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis. Ann Rheum Dis 2003; 62: 630-634.
18. Weigert AL, Higa EM, Niederberger M, McMurtry IF, Raynolds M, Schrier RW. Expression and preferential inhibition of inducible nitric oxide synthase in aortas of endotoxemic rats. J Am Soc Nephrol 1995; 5: 2067-2072.
19. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000; 17: 171-180.
20. Tsukada T, Yokoyama K, Arai T et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998; 245: 190-193.
21. Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis. Lupus 2004; 13: 188-191.
22. Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-Converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J Rheumatol 2004; 31: 1756-1762.
23. Heutink P, Oostra BA. Gene finding in genetically isolated populations. Hum Mol Genet 2002; 11: 2507-2515.
24. Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999; 8: 1913-1923.
25. Tan EM, Cohen AD, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
26. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
27. Miyahara K, Kawamoto T, Sase K et al. Cloning and structural characterization of the human endothelial nitric oxide synthase gene. Eur J Biochem 1994; 223: 719-726.
28. Rothman K. Modern Epidemiology. Boston, Toronto: Little Brown, 1998.
29. Burg M, Menne J, Ostendorf T, Kliem V, Floege J. Gene polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. Clin Nephrol 1997; 48: 205-211.
30. Yokoyama K, Tsukada T, Matsuoka H, Hara S, Yamada A, Kawaguchi Y. High accumulation of endothelial nitric oxide synthase (ecNOS): a gene polymorphism in patients with end-stage renal disease. Nephron 1998; 79: 360-361.
31. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000; 57: 405-413.
32. Wang Y, Kikuchi S, Suzuki H, Nagase S, Koyama A. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. Nephrol Dial Transplant 1999; 14: 2898-2902.
33. Wang XL. Cigarette smoking, DNA variants in endothelial nitric oxide synthase gene and vascular disease. Contrib Nephrol 2000; 130: 53-67.
34. Gonzalez-Gay MA, Lilorca J, Sanchez E et al. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology 2004; 4: 1182-1185.
35. Tolins JP, Palmer RMJ, Moncada S, Raij L. The role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990; 258: 655-662.
36. Spanaki C, Plaitakis A. Bilineal transmission of Parkinson disease on Crete suggests a complex inheritance. Neurology 2004; 62: 815-817.